Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

47.4K
Overview
47.4K
Cancer Vaccines01:30

Cancer Vaccines

582
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
582
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

543
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
543
Conjugated Proteins02:50

Conjugated Proteins

21.8K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
21.8K
FDA Approved Drugs: Changes to Approved Drugs01:26

FDA Approved Drugs: Changes to Approved Drugs

32
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
32
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

17.0K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

COVID-19-associated neurological and psychological manifestations.

Nature reviews. Disease primers·2025
Same author

Decidual macrophages as therapeutic targets in preterm labour.

Trends in molecular medicine·2025
Same author

Dynamic roles of ILC3 in endometrial repair and regeneration.

Discovery immunology·2025
Same author

Vaccination in pregnancy to protect the newborn.

Nature reviews. Immunology·2025
Same author

COVID-19 vaccination and birth outcomes of 186,990 women vaccinated before pregnancy: an England-wide cohort study.

The Lancet regional health. Europe·2025
Same author

Inflammatory Monocytes Are Rapidly Recruited to the Post-Ischaemic Liver in Patients Undergoing Liver Transplantation and Cytokines Associated with Their Activation Correlate with Graft Outcomes.

Current issues in molecular biology·2025

Related Experiment Video

Updated: Oct 27, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

3.0K

COVID-19 vaccines: what do we know so far?

Paraminder Dhillon1, Daniel Altmann2, Victoria Male3

  • 1The FEBS Journal Editorial Office, Cambridge, UK.

The FEBS Journal
|July 21, 2021
PubMed
Summary

The rapid development of COVID-19 vaccines, including novel RNA vaccines, was achieved through unprecedented scientific collaboration. This article explains vaccine development, function, safety, and efficacy, addressing public concerns about coronavirus disease 2019 (COVID-19) vaccines.

More Related Videos

Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses
05:49

Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses

Published on: November 21, 2023

2.0K
Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research
06:08

Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research

Published on: September 8, 2023

1.4K

Related Experiment Videos

Last Updated: Oct 27, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

3.0K
Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses
05:49

Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses

Published on: November 21, 2023

2.0K
Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research
06:08

Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research

Published on: September 8, 2023

1.4K

Area of Science:

  • Vaccinology and Virology
  • Immunology
  • Public Health

Background:

  • The emergence of SARS-CoV-2 in late 2019 necessitated rapid vaccine development.
  • Over 100 vaccine candidates were in development within a year, with several approved for use.
  • The COVID-19 pandemic accelerated the adoption of next-generation vaccinology technologies, notably RNA vaccines.

Discussion:

  • The article provides an overview of the vaccine development process for SARS-CoV-2.
  • It explains the mechanisms by which vaccines generate a robust immune response.
  • Common questions regarding vaccine safety and efficacy are addressed.

Key Insights:

  • Vaccine development against SARS-CoV-2 occurred at record speed due to global collaboration.
  • RNA vaccine technology, refined over years, emerged as a frontrunner.
  • Despite accelerated timelines, critical safety and efficacy evaluations were maintained.

Outlook:

  • Addressing public skepticism regarding COVID-19 vaccine benefits and risks is crucial.
  • Continued research and transparent communication are vital for vaccine acceptance.
  • The pandemic has paved the way for future advancements in rapid vaccine development and deployment.